Last reviewed · How we verify
NCT04253600
Understanding the Predictive Factors and the Neurocognitive Basis of Developmental Language Disorder
NA trial testing Risk profile screening questionnaire in Developmental Language Disorders in 1,500 participants. Status unknown.
1 August 2022
Quick facts
| Lead sponsor | Université Catholique de Louvain |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 1,500 |
| Start date | 1 April 2020 |
| Primary completion | 1 August 2022 |
| Estimated completion | 31 August 2024 |
| Sites | 2 locations across Belgium |
Drugs / interventions tested
- Risk profile screening questionnaire
- Investigation of the neural correlates of DLD using Magnetic Resonance Imagery (MRI)
- Online investigation of predictive factors associated with DLD and LANCOM app development
- Individual behavioral and cognitive assessment
- Automated analysis of language development and environment
Conditions studied
- Developmental Language Disorders — all drugs for Developmental Language Disorders →
- Language Development — all drugs for Language Development →
Sponsor
Université Catholique de Louvain — full company profile →
Who can join
Under 18 Months, any sex, with Developmental Language Disorders or Language Development. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
For most children, language acquisition might appear like an effortless phenomenon, mostly arising from informal daily interaction with their surrounding people. Despite an adequate learning environment however, some children encounter major difficulties in learning their native tongue and develop a Developmental Language Disorder (DLD). Although the existence of a multi-factorial etiology has seemed to reach an agreement, presumably combining genetic and environmental factors to some kind of neural disruption, the underlying mechanisms leading to DLD are, to date, poorly understood. Many studies have attempted to identify risk factors and early predictors associated with the future development of a language impairment. However, despite the constant efforts to identify early markers able to differentiate between transient and persistent language difficulties, early detection of children who will be developing a DLD remains highly difficult, partially due to the lack of direct and ecological measures of early language and communication development. In addition research on the causal neural correlates of DLD is in its infancy, and often compromised by small sample sizes or analyses methods that lack anatomical specificity to determine the neural correlates of language impairment. Hence, In order to improve early detection and, therefore, language intervention, this longitudinal research project aims at investigating the early predictive factors as well as the neurocognitive basis of DLD by means of an integrative, multi-dimensional, and multi-methodological approach. To substantially gain insight, this research ideally integrates risk factors at multiple different levels, including the cognitive, neurobiological, parental and environmental level. From a methodological perspective, we will combine direct and indirect behavioral methods with neuroimaging methods in order to propose an early predictive model of language development.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04253600
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Developmental Language Disorders
Currently open trials in the same condition.
- NCT06911138 — Treating Complex Grammar Knowledge Deficits in School-Age Children With Developmental Language Disorder · NA · recruiting
Other Université Catholique de Louvain trials
Trials by the same sponsor.
- NCT07453524 — Assessing Chronic Pain Patient Preferences · NA · not yet recruiting
- NCT07422909 — Bridging the Gap: Implementing BRIDGES · NA · not yet recruiting
- NCT07420231 — Evaluation of the Synergistic Effect of Combining a Prebiotic and a Postbiotic on Intestinal Discomfort · NA · not yet recruiting
- NCT07360223 — Internalized Symptoms in Adolescents With Autism Spectrum Disorder (ASD) and Typically Developing Adolescents : Gaining · not yet recruiting
- NCT07263971 — Birth Experience of Women Giving Birth in Belgium · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04253600 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Université Catholique de Louvain
- Last refreshed: 5 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04253600.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing